T/CACM 010-2017 Active Group standards

T/CACM 010-2017 Guidelines for Clinical Practice on the Use of Traditional Chinese Medicine Monotherapy/Combination with Antibiotics for the Treatment of Common Infectious Diseases: Pelvic Inflammatory Disease (PID)

T/CACM 010-2017 Guidelines for Clinical Practice on the Use of Traditional Chinese Medicine Monotherapy/Combination with Antibiotics for the Treatment of Common Infectious Diseases: Pelvic Inflammatory Disease (PID)

Publish Date: 2016-06-07 Implement Date: 2016-06-07 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 010-2017
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Health
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2016-06-07
Implement Date: 2016-06-07

Scope

Main technical content: With the significant changes in social environmental factors, the prevalence of pelvic inflammatory disease (PID) has remained at a high level. Currently, Western medicine primarily uses broad-spectrum antibiotics for the treatment of PID. However, the optimal treatment regimen and the long-term outcomes of early-stage disease treatment remain uncertain, especially as antibiotics need to be constantly updated to ensure their efficacy against increasingly drug-resistant pathogens. Traditional Chinese medicine (TCM) contains complex components with multiple targets of action, making it less susceptible to bacterial resistance. Long-term clinical practice has shown that TCM alone or in combination with antibiotics can improve clinical efficacy, shorten the course of the disease, and reduce the occurrence of sequelae. However, there are currently no standardized guidelines for the use of TCM alone or in combination with antibiotics in the treatment of PID, making it urgent to develop relevant guidelines to fully leverage the role of TCM in the treatment of PID. Referencing the methodology and process of international clinical practice guidelines, and guided by relevant laws, regulations, and technical documents, this guideline aims to integrate the best available evidence, clinical expert experience, and patient preferences with current practical circumstances to form evidence-based clinical practice guidelines for the use of TCM alone or in combination with antibiotics in the treatment of PID, in order to guide clinicians in the rational and standardized application of TCM in the treatment of PID, reduce antibiotic use and drug resistance, mitigate clinical medication risks, and improve clinical efficacy. Due to the influence of factors such as geography, ethnicity, and race on users, this guideline should be implemented in accordance with local and current practical circumstances.

Development Information

Related Standards

Contact Us